RIKEN VITAMIN CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,647 JPY | +2.92% |
|
+4.50% | +18.43% |
| May. 22 | Riken Vitamin Co., Ltd. Resolves to Pay Year-End Dividend for the Year Ending 31 March 2024, Payable on June 10, 2024 | CI |
| May. 10 | Riken Vitamin Co., Ltd. Revises Year-End Dividend Guidance | CI |
Strengths
- The company's attractive earnings multiples are brought to light by a P/E ratio at 9.45 for the current year.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
Ratings chart - Surperformance
Sector: Food Processing
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +18.43% | 498M | - | - | |
| -2.00% | 273B | A- | ||
| -6.33% | 91.06B | C+ | ||
| -5.35% | 42.08B | C+ | ||
| +0.75% | 41.06B | B- | ||
| +5.13% | 39.06B | B- | ||
| +4.41% | 37.63B | B- | ||
| -15.18% | 29.74B | B- | ||
| -11.43% | 27.84B | A | ||
| +7.73% | 25.27B | A- |
Investor Rating
-
Trading Rating
-
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
Momentum
1 year Revenue revision
-
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
-
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
-
4m Target Price Revision
-
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
-
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
-
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- 4526 Stock
- Ratings Riken Vitamin Co., Ltd.
